CED Cannabis Science Digest: 3 Lower-Certainty Signals Worth Watching
No fresh cannabis paper cleared CED Clinic's high-threshold lead-post bar on June 18, 2026, but three verified lower-certainty signals on insomnia, impaired driving, and legal-market pricing were still worth preserving. The cannabis insomnia trial…
CB2 Agonists and the Blood-Brain Barrier: Why This Preclinical Signal Is Still Early
CB2 receptor agonists neuroinflammation research shows promising anti-inflammatory effects on the blood-brain barrier in preclinical models. This early signal highlights mechanistic insights but lacks human clinical evidence. Further studies are needed…
Dronabinol for Chronic Low Back Pain: What the Veterans Trial Will Actually Test
A new dronabinol chronic low back pain trial protocol focuses on safety and tolerability in Veterans. This phase IIa study will test oral dronabinol versus placebo. It is designed to inform future research, not prove efficacy.
Cannabinoids and the Aging Brain: Why Dose and Product Type Matter
A 2026 review highlights how cannabinoid therapy aging brain effects depend on dose, product type, and aging physiology. The findings emphasize careful, age-adapted decisions over broad claims. This supports safer cannabis use tailored to older adults'…
Cannabinoids and Inflammation: A Systematic Review of Clinical Evidence
Cannabinoid use inflammatory biomarkers show complex associations with both pro- and anti-inflammatory markers. Clinical evidence reveals nuanced immunomodulatory effects rather than a simple inflammatory shift. Understanding these biomarkers is critical…
Exploring the Endocannabinoid System in Opioid Use Disorder and Pain
A 2026 review explores the endocannabinoid system opioid use disorder connection and its potential role in managing pain and withdrawal symptoms. The biology is plausible but clinical translation remains limited by small studies and mixed designs. This…
Cannabis and Cognition in Adolescents and Young Adults: A New Systematic Review
A 2026 systematic review highlights adolescent cannabis memory effects as the most consistent cognitive difference in young users. Memory-related findings, especially episodic and working memory, stand out more than other cognitive domains. This review…
Cannabinoids for Cancer Pain: New Review Questions the Opioid-Sparing Claim
A 2026 systematic review and meta-analysis found cannabinoids did not reliably reduce opioid use in controlled cancer-pain studies. This challenges the opioid-sparing cancer pain claim often made in clinical discussions. The findings suggest cannabinoids…
Cannabis Use and Poor Mental Health: What the New U.S. Trends Show
The 2023 cannabis mental health data reveals an increase in poor mental health days among adults reporting cannabis use. This large U.S. survey highlights the need for better mental health screening. However, it does not prove cannabis caused the trend.
High-Dose CBD for Spinal Cord Injury Nerve Pain
The high-dose cannabidiol neuropathic pain trial showed modest reduction in spinal cord injury nerve pain. This randomized crossover study tested doses up to 800 mg daily. Results indicate a credible analgesic signal but do not support unsupervised…